EAP August Newsletter
KETAMINE: What Flight Attendants Should Know
Understanding its Use, Effects, and Workplace Implications
Presented by AFA EAP / Professional Standards
What is Ketamine?
Ketamine is a dissociative anesthetic that has been used for decades in medical settings for surgery and pain anagement.
More recently, it has gained attention for its off-label use in treating depression and PTSD, often when other treatments
have failed. Ketamine is administered in clinics under medical supervision, usually through intravenous (IV) infusions,
nasal spray (esketamine), or intramuscular injection.
Why Are People Talking About It?
Mental health care providers are exploring new treatment options for conditions like treatment-resistant depression. In
some cases, ketamine can offer rapid relief from severe symptoms. However, this doesn’t mean it’s without risks or that
it’s right for everyone.
Is It Legal?
Yes—ketamine is a Schedule III controlled substance in the U.S., meaning it has accepted medical uses but also potential
for misuse. Only licensed providers can administer it. The nasal spray version, Spravato (esketamine), is FDA-approved for
depression and is used in certified clinics.
Short-term effects include:
Altered perception of time and space
Detachment from surroundings or body
Mild hallucinations
Drowsiness and dizziness
Elevated heart rate and blood pressure
Safety-Sensitive Implications for Flight Attendants
As a DOT-regulated, safety-sensitive employee, you must be fit for duty at all times. This includes residual impairment
that results from returning to work too soon after treatment.
Need Support?
Your AFA EAP/Professional Standards Committee is here to help—confidentially and without judgment. Whether you’re
exploring mental health treatment, facing challenges with a coworker, or unsure about a medication, you don’t have to
go it alone.
Contact AFA EAP anytime. 800-424-2406
EAP Chair – Lynnette Clark – 503-729-4439
LEC 16 EAP LEC & Reps
Anne Strand (LEC) – 206-940-4634
Kim Van Wormer – 509-308-9553
Miria Davis – 208-398-8612
LEC 17 EAP LEC & Reps
Carrie Dennis (LEC) – 360-600-5988
Peter Oxentenko – 503-888-7271
Chris Metz – 217-369-8735
EAP August Newsletter
KETAMINE: What Flight Attendants Should Know
Understanding its Use, Effects, and Workplace Implications
Presented by AFA EAP / Professional Standards
What is Ketamine?

Message from the MEC on First Class Service Change Notificaiton (7-12-25)
Read More > Message from the MEC on First Class Service Change Notificaiton (7-12-25)